Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entecavir for HBV Prophylaxis Post-Liver Transplant
NCT01139203Phase 4Unknown
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Aug 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of entecavir in hepatitis B (HBV) (3 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Serological markers of HBV. Status: unknown.
02
Drugs
entecavir
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT01139203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01139203.